$EPZM Epizyme, Inc. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Epizyme, Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in Epizyme, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Epizyme, Inc. for free.

CIK Number: 0001571498
IRS Number: 261349956
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: EPZM
Company Address: 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE 02139

Epizyme, Inc. is a clinical-stage biopharmaceutical company, which engage in the discovery, development, and commercialization of novel epigenetic medicines for cancer and other diseases. Its product pipeline is lead by, tazemetostat which targets Non-Hodgkin Lymphoma, molecularly defined solid tumors, non-small-cell lung carcinoma, molecularly targeted tumors, and ovarian cancer. It also develops pinometostat for genetically defined acute leukemia, and EZM8266 for sickle cell disease. The company was founded by Robert Horvitz and Zhang Yi on November 1, 2007 and is headquartered in Cambridge, MA.

Market Capitalization: $707.73M
Prev close: $12.05
Average Daily Volume: 337,735
Days Low: $11.95
Year Low: $7.02
Year High: $13.46

Epizyme, Inc. Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
Agarwal ShefaliChief Medical Officer35,699430,173shares bought: 69,788 / shares sold: -1,195 STRONG BUYJun 17 20192 months ago
Allen Andrew RDirector00Jun 07 20192 months ago
BATE KENNETHDirector00Jun 07 20192 months ago
Bazemore Robert BPresident & CEO87,0681,049,169shares bought: 159,128 / shares sold: -2,074 STRONG BUYJun 14 20192 months ago
Beaulieu JosephCorporate Controller7008,435shares bought: 700 / shares sold: -203 BUYJun 14 20192 months ago
Conroy Kevin TDirector4,66256,177shares bought: 4,662 / shares sold: 0 STRONG BUYJul 02 20192 months ago
Giordano Michael FDirector00Jun 07 20192 months ago
GOLDFISCHER CARLDirector3,380,95140,740,460Jun 07 20192 months ago
MOTT DAVID MDirector00shares bought: 1,594,209 / shares sold: -3,424,917 STRONG SELLJun 28 20192 months ago
POPS RICHARD FDirector00Jun 07 20192 months ago
Ros MatthewSee Remarks40,217484,615shares bought: 143,760 / shares sold: -73,449 STRONG BUYJun 14 20192 months ago
SEIDENBERG BETH CDirector7,47190,026shares bought: 7,471 / shares sold: 0 STRONG BUYJun 07 20192 months ago

View all Epizyme, Inc. insiders.

Epizyme, Inc. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jul 02 2019EPZMEpizyme, Inc.Conroy Kevin TDirectorGrantA12.5588711,1324,6623.8 K to 4.7 K (+23.50 %)
Jun 28 2019EPZMEpizyme, Inc.MOTT DAVID MDirectorSellS12.4352,473652,134052.5 K to 0 (-100.00 %)
Jun 26 2019EPZMEpizyme, Inc.MOTT DAVID MDirectorSellS12.8552,472674,17652,473104.9 K to 52.5 K (-50.00 %)
Jun 26 2019EPZMEpizyme, Inc.MOTT DAVID MDirectorSellS13.3152,472698,649104,945157.4 K to 104.9 K (-33.33 %)
Jun 26 2019EPZMEpizyme, Inc.MOTT DAVID MDirectorBuyJ0.00157,4170157,4170 to 157.4 K
Jun 26 2019EPZMEpizyme, Inc.MOTT DAVID MDirectorBuyJ0.0038,646039,297651 to 39.3 K (+5,936.41 %)
Jun 26 2019EPZMEpizyme, Inc.MOTT DAVID MDirectorSellJ0.00767,50000767.5 K to 0 (-100.00 %)
Jun 26 2019EPZMEpizyme, Inc.MOTT DAVID MDirectorBuyJ0.00767,5000767,5000 to 767.5 K
Jun 26 2019EPZMEpizyme, Inc.MOTT DAVID MDirectorSellJ0.002,500,00003,971,0186.5 M to 4 M (-38.63 %)
Jun 17 2019EPZMEpizyme, Inc.Agarwal ShefaliChief Medical Offic ...SellS11.971,19514,30435,69936.9 K to 35.7 K (-3.24 %)
Jun 14 2019EPZMEpizyme, Inc.Beaulieu JosephCorporate Controlle ...SellS12.102032,456497700 to 497 (-29.00 %)
Jun 14 2019EPZMEpizyme, Inc.Beaulieu JosephCorporate Controlle ...GrantA0.0070007000 to 700
Jun 14 2019EPZMEpizyme, Inc.Agarwal ShefaliChief Medical Offic ...GrantA0.004,000036,89432.9 K to 36.9 K (+12.16 %)
Jun 14 2019EPZMEpizyme, Inc.Ros MatthewSee RemarksSellS12.101,18514,33939,03240.2 K to 39 K (-2.95 %)
Jun 14 2019EPZMEpizyme, Inc.Ros MatthewSee RemarksGrantA0.004,000040,21736.2 K to 40.2 K (+11.04 %)

View all Epizyme, Inc. insider transactions.